Comparison of the efficacy of two different glucocorticoid regimens for treatment of active moderate-to-severe Graves’ orbitopathy

被引：0
作者：
Mariya Asenova Stoynova
Alexander Dimitrov Shinkov
Inna Dimitrova Dimitrova
Inna Angelova Yankova
Roussanka Dimitrova Kovatcheva
机构：
[1] Medical University of Sofia,Department of Endocrinology
[2] University Hospital of Endocrinology,undefined
来源：
International Ophthalmology | 2023年 / 43卷
关键词：
Graves’ orbitopathy; Glucocorticoid regimens; Efficacy; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4747 / 4757
页数：10
相关论文
共 50 条
[21]   Glucocorticoid-induced adrenal insufficiency after therapy with intravenous methylprednisolone in patients with moderate-to-severe and active Graves' orbitopathy: assessment with a low-dose corticotropin test [J].
Pelewicz, K. ;
Miskiewicz, P. .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2024, 47 (08) :1987-1994
[22]   Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trial [J].
Kahaly, George J. ;
Riedl, Michaela ;
Koenig, Jochem ;
Pitz, Susanne ;
Ponto, Katharina ;
Diana, Tanja ;
Kampmann, Elena ;
Kolbe, Elisa ;
Eckstein, Anja ;
Moeller, Lars C. ;
Fuehrer, Dagmar ;
Salvi, Mario ;
Curro, Nicola ;
Campi, Irene ;
Covelli, Danila ;
Leo, Marenza ;
Marino, Michele ;
Menconi, Francesca ;
Marcocci, Claudio ;
Bartalena, Luigi ;
Perros, Petros ;
Wiersinga, Wilmar M. .
LANCET DIABETES & ENDOCRINOLOGY, 2018, 6 (04) :287-298
[23]   Risk Factors for Ocular Surface Irritation Symptoms in Inactive Mild and Moderate-to-Severe Graves' Orbitopathy [J].
Yu, Yun ;
Hu, Yu-xin ;
Lu, Ming-xi ;
Ouyang, Zheng-long ;
Xu, Ming-tong ;
Zhao, Li-yan ;
Wang, Mei .
OPHTHALMOLOGY AND THERAPY, 2024, 13 (04) :1015-1024
[24]   Prognostic significance of thyroid-stimulating hormone receptor antibodies in moderate-to-severe graves' orbitopathy [J].
Park, Jungyul ;
Kim, Jaehyun ;
Kim, Sang Soo ;
Choi, Hee-Young .
FRONTIERS IN ENDOCRINOLOGY, 2023, 14
[25]   Risk Factors for Ocular Surface Irritation Symptoms in Inactive Mild and Moderate-to-Severe Graves’ Orbitopathy [J].
Yun Yu ;
Yu-xin Hu ;
Ming-xi Lu ;
Zheng-long Ouyang ;
Ming-tong Xu ;
Li-yan Zhao ;
Mei Wang .
Ophthalmology and Therapy, 2024, 13 :1015-1024
[26]   Therapy of moderate-to-severe Graves’ orbitopathy with intravenous methylprednisolone pulses is not associated with loss of bone mineral density [J].
Joanna Rymuza ;
Michał Popow ;
Zuzanna Żurecka ;
Jerzy Przedlacki ;
Tomasz Bednarczuk ;
Piotr Miśkiewicz .
Endocrine, 2019, 64 :308-315
[27]   Therapy of moderate-to-severe Graves' orbitopathy with intravenous methylprednisolone pulses is not associated with loss of bone mineral density [J].
Rymuza, Joanna ;
Popow, Michal ;
Zurecka, Zuzanna ;
Przedlacki, Jerzy ;
Bednarczuk, Tomasz ;
Miskiewicz, Piotr .
ENDOCRINE, 2019, 64 (02) :308-315
[28]   A pilot study on the use of prednisolone-encapsulated liposomes for the treatment of moderate-to-severe Graves' orbitopathy with reduced systemic steroid exposure [J].
Detiger, Sanne E. ;
Kremer, Tessa M. ;
A.S.H. Dalm, Virgil ;
de Keizer, Ronald O. B. ;
Wubbels, Rene J. ;
Metselaar, J. M. ;
van Hagen, P. Martin ;
Peeters, Robin P. ;
Paridaens, Dion .
ACTA OPHTHALMOLOGICA, 2021, 99 (07) :797-804
[29]   Efficacy of B-Cell Targeted Therapy With Rituximab in Patients With Active Moderate to Severe Graves' Orbitopathy: A Randomized Controlled Study [J].
Salvi, Mario ;
Vannucchi, Guia ;
Curro, Nicola ;
Campi, Irene ;
Covelli, Danila ;
Dazzi, Davide ;
Simonetta, Simona ;
Guastella, Claudio ;
Pignataro, Lorenzo ;
Avignone, Sabrina ;
Beck-Peccoz, Paolo .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (02) :422-431
[30]   Efficacy and safety of dupilumab for the treatment of moderate-to-severe atopic dermatitis in adults [J].
Xu, Xinghua ;
Zheng, Yi ;
Zhang, Xin ;
He, Yanling ;
Li, Chengxin .
ONCOTARGET, 2017, 8 (65) :108480-108491
12345